Pharmaceutical firms moving to sell OTC drugs

Korean drug makers are seeking a breakthrough in their sluggish ethical sector by entering the promising over-the-counter (OTC) market that will bring greater revenue, under the government’s shake-up in the pharmaceutical sector that will result in average drug price cuts of 17 percent starting in 2012.

“We will focus on strengthening our OTC business in a bid to diversify our income sources...